ATE546543T1 - Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase - Google Patents

Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase

Info

Publication number
ATE546543T1
ATE546543T1 AT08765357T AT08765357T ATE546543T1 AT E546543 T1 ATE546543 T1 AT E546543T1 AT 08765357 T AT08765357 T AT 08765357T AT 08765357 T AT08765357 T AT 08765357T AT E546543 T1 ATE546543 T1 AT E546543T1
Authority
AT
Austria
Prior art keywords
epha4
secretase
screening method
new substrate
gamma secretase
Prior art date
Application number
AT08765357T
Other languages
English (en)
Inventor
Eiji Inoue
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE546543T1 publication Critical patent/ATE546543T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT08765357T 2007-06-08 2008-06-09 Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase ATE546543T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94268707P 2007-06-08 2007-06-08
PCT/JP2008/060567 WO2008150010A1 (ja) 2007-06-08 2008-06-09 γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法

Publications (1)

Publication Number Publication Date
ATE546543T1 true ATE546543T1 (de) 2012-03-15

Family

ID=40093812

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08765357T ATE546543T1 (de) 2007-06-08 2008-06-09 Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase

Country Status (5)

Country Link
US (2) US7910324B2 (de)
EP (1) EP2166110B1 (de)
JP (1) JP5511377B2 (de)
AT (1) ATE546543T1 (de)
WO (1) WO2008150010A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008150010A1 (ja) 2007-06-08 2008-12-11 Eisai R & D Management Co., Ltd. γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法
JPWO2009011426A1 (ja) * 2007-07-19 2010-09-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質c−Metを利用したスクリーニング方法
EP2192181A4 (de) * 2007-08-01 2010-12-08 Eisai R&D Man Co Ltd Screening-verfahren mit nutzung des neuen substrats c-ret für gamma-sekretase
EP2219028B1 (de) 2007-11-15 2012-09-12 Eisai R&D Management Co., Ltd. Screening-verfahren mit nutzung des neuen substrats epha7 für gamma-sekretase
DK2223999T3 (en) 2007-11-30 2017-12-18 Eisai R&D Man Co Ltd EPHA4 POLYPEPTIDE WITH UNKNOWN ACTIVITY AND USE THEREOF
WO2010141974A1 (en) * 2009-06-10 2010-12-16 The University Of Melbourne Therapeutic applications
DK2653552T3 (en) 2010-12-17 2017-01-16 Eisai R&D Man Co Ltd SCREENING METHOD USING GELATINASE-MEDIATED EphA4 DIVISION REACTION AS INDICATOR
WO2012147798A1 (ja) 2011-04-25 2012-11-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 EphA4細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法
AR105938A1 (es) 2015-09-08 2017-11-22 Eisai R&D Man Co Ltd Anticuerpo anti-epha4
CA3003294A1 (en) * 2015-10-27 2017-05-04 The University Of Queensland Modified epha4 and uses thereof
PE20220570A1 (es) 2019-07-01 2022-04-20 Eisai Randd Man Co Ltd Anticuerpo anti-epha4 humano
CN116710133A (zh) * 2020-12-24 2023-09-05 卫材R&D管理有限公司 肌萎缩侧索硬化的治疗用药物组合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020068361A1 (en) * 1997-04-08 2002-06-06 Douglas Clary Methods of evaluating specific cellular functions of receptor protein tyrosine kinases in a ligand independent manner
WO1998045708A1 (en) 1997-04-08 1998-10-15 Sugen, Inc. Study and treatment of diseases related to specific cellular functions of receptor protein tyrosine kinases
US20070015145A1 (en) 2001-08-14 2007-01-18 Clifford Woolf Nucleic acid and amino acid sequences involved in pain
US20070026409A1 (en) * 2001-08-14 2007-02-01 The General Hospital Corporation Nucleic acid and amino acid sequences involved in pain
US20060241074A1 (en) * 2001-08-14 2006-10-26 The General Hospital Corporation Methods for treatment of pain
JP2003169699A (ja) * 2001-12-10 2003-06-17 Japan Science & Technology Corp 特異的γプロテアーゼ阻害剤のスクリーニング方法
JP2004000060A (ja) 2002-05-31 2004-01-08 Otsuka Pharmaceut Co Ltd アミロイドβ産生に影響を与える化合物のスクリーニング方法
ES2293047T3 (es) 2002-11-26 2008-03-16 PHARMACIA & UPJOHN COMPANY LLC Sustratos basados en notch solubles para gamma secretasa y procedimientos y composiciones para usarlos.
EP1693449A4 (de) 2003-11-10 2007-07-25 Osaka Ind Promotion Org Zellfreies notch-spaltungsanalyseverfahren und arzneistoff-screening-verfahren
JP2007525203A (ja) 2004-02-27 2007-09-06 オンコセラピー・サイエンス株式会社 PRCおよびPDACaの治療標的としてのEphA4
EP1662259A1 (de) * 2004-11-25 2006-05-31 Cellzome Ag Verwendung von Eph Rezeptor-Inhibitoren zur Behandlung von neurodegenerativen Erkrankungen
GB0427023D0 (en) * 2004-12-09 2005-01-12 Merck Sharp & Dohme Assay method
US20070051145A1 (en) * 2005-09-02 2007-03-08 Ez Trend Technology Co.,Ltd Electric lock
EP1947193A1 (de) * 2007-01-17 2008-07-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Screening-Verfahren für antidiabetische Zusammensetzungen
WO2008150010A1 (ja) 2007-06-08 2008-12-11 Eisai R & D Management Co., Ltd. γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法
US20090023158A1 (en) * 2007-07-13 2009-01-22 Elan Pharmaceuticals, Inc. Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
JPWO2009011426A1 (ja) * 2007-07-19 2010-09-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質c−Metを利用したスクリーニング方法
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
DK2223999T3 (en) * 2007-11-30 2017-12-18 Eisai R&D Man Co Ltd EPHA4 POLYPEPTIDE WITH UNKNOWN ACTIVITY AND USE THEREOF
US20100113415A1 (en) * 2008-05-29 2010-05-06 Rajapakse Hemaka A Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer

Also Published As

Publication number Publication date
JP5511377B2 (ja) 2014-06-04
EP2166110B1 (de) 2012-02-22
EP2166110A1 (de) 2010-03-24
JPWO2008150010A1 (ja) 2010-08-26
US7910324B2 (en) 2011-03-22
US20090142788A1 (en) 2009-06-04
US8137926B2 (en) 2012-03-20
WO2008150010A1 (ja) 2008-12-11
EP2166110A4 (de) 2010-07-28
US20110111444A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
ATE546543T1 (de) Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
ATE535612T1 (de) Toxizitätsscreeningverfahren
ATE526333T1 (de) Reagentien zum nachweis von hypochloriger säure
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
WO2009011426A1 (ja) γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法
ATE475085T1 (de) Biosensor und verfahren zu dessen herstellung
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
NO20080371L (no) Fremgangsmate for a forutsi responsen overfor en behandling
DE602006021223D1 (de) Verfahren zur identifizierung von trpv2-modulatoren
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
EA200701742A1 (ru) Способы получения сиропа
WO2009064006A1 (ja) γ-セクレターゼの新規基質EphA7を利用したスクリーニング方法
ATE525462T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
NO20064100L (no) Fremgangsmate for a evaluere ferskheten til et fiskeprodukt
WO2008104638A3 (en) Improved homogeneous luminescence bioassay
GB0608377D0 (en) Reagents and methods
MY159867A (en) Detection and enumeration of microorganisms
WO2009017234A1 (ja) γ-セクレターゼの新規基質c-Retを利用したスクリーニング方法
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
Lee et al. How do elevated CO 2 and nitrogen addition affect functional microbial community involved in greenhouse gas flux in salt marsh system
BRPI0515161A (pt) substratos enzimáticos derivados de fenoxazinona e seu uso como revelador na detecção de microorganismos com atividade de peptidase
DK1612275T3 (da) Fremgangsmåder og sammensætninger til karakterisering af et redoxreagenssystemenzym